Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT03656926Phase 3Completed
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Bronchiolitis ObliteransChronic Lung Allograft DysfunctionChronic Rejection of Lung Transplant+3 more
StudydirectorStart date: 2019-03-26
NCT03657342Phase 3Completed
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Bronchiolitis ObliteransChronic Lung Allograft DysfunctionChronic Rejection of Lung Transplant+3 more
StudydirectorStart date: 2019-03-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03656926Phase 3StudyDirector

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

Bronchiolitis ObliteransChronic Lung Allograft DysfunctionChronic Rejection of Lung Transplant+3 more
Completed
NCT03657342Phase 3StudyDirector

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

Bronchiolitis ObliteransChronic Lung Allograft DysfunctionChronic Rejection of Lung Transplant+3 more
Completed

All 2 trials loaded